Andersons pediatric cardiology 239
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (60.61 KB, 3 trang )
Fetalechocardiography.Atoolforevaluationof
inuterocardiacarrhythmiasandmonitoringof
inuterotherapy:analysisof71patients.AmJ
Cardiol.1983;51(2):237–243.
15.BenoitM,ZergerF,HeiselJ,QuevalB,MesserJ.
Fetalcongestiveheartfailureduetonodal
tachycardia:inuterodigoxintherapy.ArchFr
Pediatr.1982;39(6):379–380.
16.DumesicDA,SilvermanNH,TobiasS,Golbus
MS.Transplacentalcardioversionoffetal
supraventriculartachycardiawithprocainamide.
NEnglJMed.1982;307(18):1128–1131.
17.AllanLD,ChitaSK,SharlandGK,MaxwellD,
PriestleyK.Flecainideinthetreatmentoffetal
tachycardias.BrHeartJ.1991;65(1):46–48.
18.Frohn-MulderIM,StewartPA,WitsenburgM,et
al.Theefficacyofflecainideversusdigoxinin
themanagementoffetalsupraventricular
tachycardia.PrenatDiagn.1995;15(13):1297–
1302.
19.HansmannM,GembruchU,BaldR,ManzM,
RedelDA.Fetaltachyarrhythmias:
transplacentalanddirecttreatmentofthefetus-a
reportof60cases.UltrasoundObstetGynecol.
1991;1(3):162–168.
20.LisowskiLA,VerheijenPM,BenatarAA,etal.
Atrialflutterintheperinatalagegroup:
diagnosis,managementandoutcome.JAmColl
Cardiol.2000;35(3):771–777.
21.OudijkMA,MichonMM,KleinmanCS,etal.
Sotalolinthetreatmentoffetaldysrhythmias.
Circulation.2000;101(23):2721–2726.
22.OudijkMA,RuskampJM,VerversFF,etal.
Treatmentoffetaltachycardiawithsotalol:
transplacentalpharmacokineticsand
pharmacodynamics.JAmCollCardiol.
2003;42(4):765–770.
23.KrappM,BaschatAA,GembruchU,GeipelA,
GermerU.Flecainideintheintrauterine
treatmentoffetalsupraventriculartachycardia.
UltrasoundObstetGynecol.2002;19(2):158–
164.
24.KrappM,KohlT,SimpsonJM,etal.Reviewof
diagnosis,treatment,andoutcomeoffetalatrial
fluttercomparedwithsupraventricular
tachycardia.Heart.2003;89(8):913–917.
25.ShahA,Moon-GradyA,BhogalN,etal.
Effectivenessofsotalolasfirst-linetherapyfor
fetalsupraventriculartachyarrhythmias.AmJ
Cardiol.2012;109(11):1614–1618.
26.BarjotP,HamelP,CalmeletP,MaragnesP,
HerlicoviezM.Flecainideagainstfetal
supraventriculartachycardiacomplicatedby
hydropsfetalis.ActaObstetGynecolScand.
1998;77(3):353–358.
27.vanderHeijdenLB,OudijkMA,MantenGT,et
al.Sotalolasfirst-linetreatmentforfetal
tachycardiaandneonatalfollow-up.Ultrasound
ObstetGynecol.2013;42(3):285–293.
28.vanEngelenAD,WeijtensO,BrennerJI,etal.
Managementoutcomeandfollow-upoffetal
tachycardia.JAmCollCardiol.
1994;24(5):1371–1375.
29.SridharanS,SullivanI,TomekV,etal.
Flecainideversusdigoxinforfetal
supraventriculartachycardia:comparisonoftwo
drugtreatmentprotocols.HeartRhythm.
2016;13(9):1913–1919.
30.StrizekB,BergC,GottschalkI,etal.High-dose
flecainideisthemosteffectivetreatmentoffetal
supraventriculartachycardia.HeartRhythm.
2016;13(6):1283–1288.
31.Ekman-JoelssonBM,MellanderM,Lagnefeldt
L,SonessonSE.Foetaltachyarrhythmia
treatmentremainschallengingevenifthevast
majorityofcaseshaveafavourableoutcome.
ActaPaediatr.2015;104(11):1090–1097.
32.EkizA,KayaB,BornaunH,etal.Flecainideas
first-linetreatmentforfetalsupraventricular
tachycardia.JMaternFetalNeonatalMed.
2017;1-6.
